Viatris (VTRS) Share-based Compensation (2020 - 2026)

Viatris' (VTRS) quarterly Share-based Compensation came in at $56.5 million in Q1 2026, up 92.83% year-on-year from $29.3 million in Q1 2025, and up 157.59% quarter-over-quarter from -$98.1 million in Q4 2025.

Viatris (VTRS) Share-based Compensation (2020 - 2026) Analysis & Trends

Viatris' Share-based Compensation history runs 7 years deep, the most recent figure standing at $56.5 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 92.83% year-over-year to $56.5 million in Q1 2026; TTM through Mar 2026 was $57.4 million, a 60.87% decrease from a year earlier, with the FY2025 full-year figure at $30.2 million, down 79.33% from the prior year.
  • Share-based Compensation climbed to $56.5 million in Q1 2026 per VTRS's latest filing, from -$98.1 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $94.9 million in Q3 2023 and bottomed at -$98.1 million in Q4 2025.
  • The 5-year median for Share-based Compensation is $29.5 million (2022), against an average of $24.2 million.
  • Across the five-year window, Share-based Compensation surged 708.33% in 2022 and tumbled 392.91% in 2023, its largest moves.
  • Year by year, Share-based Compensation stood at $29.6 million in 2022, then tumbled by 392.91% to -$86.7 million in 2023, then jumped by 207.04% to $92.8 million in 2024, then plunged by 205.71% to -$98.1 million in 2025, then jumped by 157.59% to $56.5 million in 2026.
  • Per Business Quant, the three latest VTRS Share-based Compensation figures stand at $56.5 million (Q1 2026), -$98.1 million (Q4 2025), and $36.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 7.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 56.50 Mn
Mar 31, 2026 56.50 Mn
Dec 31, 2025 -98.10 Mn
Dec 31, 2025 -98.10 Mn
Sep 30, 2025 36.00 Mn
Sep 30, 2025 36.00 Mn
Jun 30, 2025 63.00 Mn
Jun 30, 2025 63.00 Mn
Mar 31, 2025 29.30 Mn
Mar 31, 2025 29.30 Mn
Dec 31, 2024 92.80 Mn
Dec 31, 2024 92.80 Mn
Sep 30, 2024 -28.10 Mn
Sep 30, 2024 -28.10 Mn
Jun 30, 2024 52.70 Mn
Jun 30, 2024 52.70 Mn
Mar 31, 2024 28.70 Mn
Mar 31, 2024 28.70 Mn
Dec 31, 2023 -86.70 Mn
Dec 31, 2023 -86.70 Mn